Business Context and Reporting Period
This unaudited Form 10-Q is for Colfax Corporation, not Enovis Corporation, for the three months ended March 29, 2013, compared with March 30, 2012. Colfax was a diversified global industrial manufacturer operating through Gas and Fluid Handling and Fabrication Technology segments under the Howden, ESAB and Colfax Fluid Handling brands. Approximately 79% of first-quarter 2013 sales came from operations outside the United States.
Key Financial Metrics
| Metric | Q1 2013 | Q1 2012 | Change |
|---|---|---|---|
| Net sales | $947.1 million | $886.4 million | Up 6.8% |
| Gross profit | $290.7 million | $241.7 million | Up $49.0 million |
| Gross margin | 30.7% | 27.3% | Up 3.4 percentage points |
| Operating income (loss) | $72.3 million | $(24.1) million | Improved $96.5 million |
| Income (loss) before taxes | $49.0 million | $(43.1) million | Improved $92.2 million |
| Net income (loss) | $32.3 million | $(100.5) million | Improved $132.7 million |
| Net income attributable to common shareholders | $22.6 million | $(109.3) million | Improved $131.9 million |
| Basic and diluted EPS | $0.21 | $(1.33) | Improved $1.54 |
| Net cash used in operating activities | $(13.4) million | $(109.3) million | Improved $95.9 million |
Segment sales were $425.1 million for Gas and Fluid Handling, essentially unchanged year over year, and $522.0 million for Fabrication Technology, up from $461.1 million. Segment operating income increased to $42.5 million from $19.8 million in Gas and Fluid Handling and to $44.5 million from $17.0 million in Fabrication Technology.
At March 29, 2013, cash and cash equivalents were $234.8 million, down from $482.4 million at December 31, 2012. Total debt was $1.530 billion, including $84.3 million classified as current. The company reported $491.9 million of availability under revolving credit subfacilities and was in compliance with its debt covenants.
Material Changes Versus the Prior Comparable Period
- Sales increased 6.8%, driven by $105.2 million of acquisition-related revenue, partially offset by a $24.0 million decline from existing businesses and a $20.5 million adverse foreign-currency translation impact.
- Gross margin improved primarily because the first quarter of 2012 included $21.4 million of acquisition-related inventory step-up expense. Cost-reduction initiatives also contributed to the improvement.
- Operating results benefited from the absence of $42.9 million of Charter acquisition-related expense recorded in Q1 2012 and lower restructuring and asbestos coverage litigation expenses.
- Q1 2012 included a $50.3 million non-cash increase in the tax valuation allowance and non-deductible or non-benefited Charter acquisition costs, contributing to the prior-period net loss and unusually high tax provision.
- Operating cash outflow improved from $109.3 million to $13.4 million, although working-capital growth, asbestos-related payments and pension contributions continued to consume cash.
- The company completed a February 2013 amendment to its Deutsche Bank credit agreement. Debt declined from $1.728 billion at December 31, 2012, primarily due to term-loan repayments.
- Foreign currency translation produced a $117.9 million loss attributable to Colfax in other comprehensive income, compared with a $117.6 million gain in Q1 2012.
Guidance, Outlook, Risks and Unusual Items
- The company expected to incur approximately $30 million of additional restructuring and related charges during the remainder of 2013.
- Management stated that available liquidity, including the Deutsche Bank credit agreement, was adequate to fund operations for the next twelve months.
- Quarterly results are seasonal, with gas- and fluid-handling shipments historically peaking in the fourth quarter and European operations typically slowing during July and August.
- Venezuela devalued its currency by approximately 32% during the quarter. Colfax recorded a $2.9 million foreign-currency transaction loss; the Venezuelan operation represented less than 1% of consolidated assets and sales.
- Asbestos-related liabilities totaled approximately $431.1 million, while related insurance assets and receivables totaled approximately $394.2 million. Management cautioned that claim activity, insurance coverage, insurer solvency and litigation outcomes could materially affect financial condition, earnings or cash flow.
- Unresolved asbestos claims totaled 23,193 at March 29, 2013. The company recognized $1.7 million of asbestos coverage litigation expense during the quarter.
- All borrowings under the amended credit agreement were variable-rate facilities. Management estimated that a 1% increase in interest rates would have increased quarterly interest expense by approximately $4.2 million.
- A 10% depreciation in major currencies relative to the U.S. dollar was estimated to reduce equity by approximately $150 million, net of specified hedges.
- On April 23, 2013, the company amended the Series A preferred stock terms so the preferred shares no longer participated proportionately in common-stock dividends or distributions. The change had no cash impact, but future diluted EPS will use the if-converted method.
Investor Verification Priorities
- Confirm the registrant identity: the supplied filing is for Colfax Corporation, while the request metadata names Enovis Corporation.
- Assess the sustainability of earnings improvement after excluding the prior-period Charter acquisition costs, inventory step-up charges and tax valuation allowance effects.
- Review debt maturities, variable-rate exposure, leverage and interest-coverage covenant headroom under the amended credit agreement.
- Reconcile cash use with working-capital growth, pension contributions, asbestos payments and planned restructuring spending.
- Evaluate the magnitude and recoverability of asbestos liabilities relative to insurance assets and receivables.
- Separate organic performance from acquisition effects, particularly in Fabrication Technology, where existing-business sales declined despite reported revenue growth.
- Monitor foreign-exchange exposure, including the Venezuelan devaluation and the substantial effect of currency translation on equity.